Mike Kelly

Adapt Pharma helps boost access to Narcan Nasal Spray

Adapt Pharma helps boost access to Narcan Nasal Spray

DUBLIN, Ireland — Adapt Pharma said its Narcan Nasal Spray over the past year has become the leading naloxone product for community use in the emergency treatment of known or suspected opioid overdose. Since the launch of Narcan (naloxone HCl 4 mg nasal spray) in February 2016, more than 730,000 doses have been distributed or